瘤样脱髓鞘病变的MRI表现:系统综述与Meta分析
该系统综述纳入19项研究共476例瘤样脱髓鞘病变患者,汇总分析常规与先进MRI表现。开环或不全环强化 pooled 发生率35%,显著高于闭环或完整环强化的18%(P=0.0281)。MRI鉴别瘤样脱髓鞘病变与原发性脑肿瘤的汇总敏感度89%、特异度94%。
要点
- 开环或不全环强化发生率35%,显著高于闭环或完整环强化的18%(P=0.0281)。
- T2低信号环、无或轻度占位效应、无或轻度瘤周水肿的汇总发生率分别为48%、67%、57%。
- MRI鉴别瘤样脱髓鞘病变与原发性脑肿瘤的汇总敏感度89%、特异度94%。
核心结论
- 常规MRI表现可能有助于鉴别瘤样脱髓鞘病变与原发性脑肿瘤,但先进MRI的附加价值尚需进一步研究确定。
研究设计与样本
- 系统综述与Meta分析,检索Ovid MEDLINE和EMBASE至2017年12月6日,纳入19项原始研究共476例瘤样脱髓鞘病变患者。
关键影像表现/征象
- 开环或不全环强化汇总发生率为35%(95%CI 24%-47%)。
- 闭环或完整环强化汇总发生率为18%(95%CI 11%-29%),显著低于开环或不全环强化(P=0.0281)。
- T2低信号环汇总发生率为48%。
- 无或轻度占位效应汇总发生率为67%。
- 无或轻度瘤周水肿汇总发生率为57%。
诊断标准与关键数值
- MRI鉴别瘤样脱髓鞘病变与原发性脑肿瘤的汇总敏感度为89%(95%CI 82%-93%)。
- MRI鉴别瘤样脱髓鞘病变与原发性脑肿瘤的汇总特异度为94%(95%CI 89%-97%)。
临床应用与阅片要点
- 开环或不全环强化、T2低信号环、无或轻度占位效应及无或轻度瘤周水肿可能提示瘤样脱髓鞘病变。
- 先进MRI上高表观扩散系数、周边受限扩散和低脑血容量可能为该病的影像特征。
局限性
- 19项研究中有17项为回顾性研究。
- 先进MRI的附加价值尚需进一步研究确定。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
BACKGROUND: Accurate diagnosis of tumefactive demyelinating lesions is clinically important to avoid unnecessary invasive biopsy or inappropriate treatment.
PURPOSE: We aimed to evaluate conventional and advanced MR imaging findings of tumefactive demyelinating lesions and determine the diagnostic performance of MR imaging for differentiating tumefactive demyelinating lesions from primary brain tumor.
DATA SOURCES: A systematic search of Ovid MEDLINE and EMBASE up to December 6, 2017, was conducted.
STUDY SELECTION: Original articles describing MR imaging findings in patients with tumefactive demyelinating lesions were selected.
DATA ANALYSIS: The pooled incidences of conventional MR imaging findings of tumefactive demyelinating lesions were obtained with the DerSimonian and Liard random-effects model. The pooled sensitivity and specificity of MR imaging for differentiating tumefactive demyelinating lesions from primary brain tumor were obtained using the bivariate random-effects model.
DATA SYNTHESIS: Nineteen eligible studies with 476 patients with tumefactive demyelinating lesions were included. The pooled incidence of open ring or incomplete rim enhancement was 35% (95% CI, 24%-47%), which was significantly higher than the incidence of closed ring or complete rim enhancement (18% [95% CI, 11%-29%]; P = .0281). The pooled incidences of T2 hypointense rim, absent or mild mass effect, and absent or mild perilesional edema were 48%, 67%, and 57%, respectively. On advanced MR imaging, tumefactive demyelinating lesions showed a high apparent diffusion coefficient, peripheral restricted diffusion, and low cerebral blood volume. The pooled sensitivity and specificity of MR imaging for differentiating tumefactive demyelinating lesions from primary brain tumor were 89% (95% CI, 82%-93%) and 94% (95% CI, 89%-97%), respectively.
LIMITATIONS: Seventeen of 19 studies were retrospective studies.
CONCLUSIONS: Conventional MR imaging findings may help differentiate tumefactive demyelinating lesions from primary brain tumor, though further study is needed to determine the added value of advanced MR imaging.
引用
- Suh CH, Kim HS, Jung SC, et al. MRI Findings in Tumefactive Demyelinating Lesions: A Systematic Review and Meta-Analysis. AJNR Am J Neuroradiol. 2018. PMID: 30115676. doi:10.3174/ajnr.A5775
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。